NIAGEN BIOSCIENCE, INC. Adjustments to Additional Paid in Capital, Other
NIAGEN BIOSCIENCE, INC. (NAGE) reported Adjustments to Additional Paid in Capital, Other of $281.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2021-03-12
- NIAGEN BIOSCIENCE, INC. adjustments to additional paid in capital, other for the quarter ending 2019-12-31 was -$1.00K.
- NIAGEN BIOSCIENCE, INC. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $282.00K.
- NIAGEN BIOSCIENCE, INC. adjustments to additional paid in capital, other for fiscal 2019 was $281.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $281.00K derived: sum of 2 quarters · filed 2021-03-12 | $281.00K 10-K · filed 2021-03-12 | $282.00K 10-K · filed 2020-03-10 | |
| 2019-09-30 | $282.00K 10-Q · filed 2020-11-04 | $282.00K 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |